🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the proportion of patients with a...
Status
Completed
Location
Johns Hopkins
Start Date
2004-03
Trial ID
NCT00081601
Treatments Being Tested
Myelofibrosis is the gradual replacement of bone marrow (place where most n...
Status
Unknown
Location
Palo Alto Medical Facilities
Start Date
2008-04
Trial ID
NCT00668421
Treatments Being Tested
An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Trea...
Status
Terminated
Location
Emory University Winship Cancer Institute
Start Date
2006-04
Trial ID
NCT00242827
Treatments Being Tested
The goal of this clinical research study is to find out if CEP-701 can help...
Status
Completed
Location
The University of Texas M.D. Anderson Cancer Center
Start Date
2007-06
Trial ID
NCT00494585
Treatments Being Tested
This is an 18-week open-label, multicenter study to evaluate the efficacy a...
Status
Completed
Location
Johns Hopkins University
Start Date
2007-12
Trial ID
NCT00586651
Treatments Being Tested
A 12-Week, Exploratory, Open-Label, Nonrandomized, Dose-Escalation Study of...
Status
Completed
Location
Wake Forest University
Start Date
2005-06
Trial ID
NCT00236119
Treatments Being Tested
The purpose of this study is to determine the response rate of patients wit...
Status
Completed
Location
Multiple Locations
Start Date
2002-01
Trial ID
NCT00030186
Treatments Being Tested
RATIONALE: CEP-701 may stop the growth of tumor cells by blocking the enzym...
Status
Completed
Location
Childrens Hospital Los Angeles
Start Date
2003-08
Trial ID
NCT00084422
Treatments Being Tested
RATIONALE: Lestaurtinib may stop the growth of cancer cells by blocking som...
Status
Completed
Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Start Date
2007-06
Trial ID
NCT00469859
Treatments Being Tested
The purpose of the study is to determine whether CEP-701 given in sequence ...
Status
Completed
Location
University of Alabama
Start Date
2003-10
Trial ID
NCT00079482
Treatments Being Tested